Liverpool, United Kingdom

Mazhar Iqbal

This inventor holds 1 USPTO granted patent. Top assignee: Charterhouse Therapeutics Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mazhar Iqbal. Retrieved from https://idiyas.com/inventor/mazhar-iqbal-r95bqahc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mazhar Iqbal: Innovator in Chemical Synthesis

Introduction

Mazhar Iqbal is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of chemistry, particularly in the development of novel chemical compounds. His work is characterized by innovative methods that have potential applications in medicine and other industries.

Latest Patents

Mazhar Iqbal holds a patent for a synthetic method and novel chemical compounds. The patent describes a method of preparing prostanoid cross-conjugated dienones through a tandem conjugate addition-Peterson olefination reaction route. This innovative approach may lead to advancements in medical applications and various other fields.

Career Highlights

Mazhar Iqbal is associated with Charterhouse Therapeutics Ltd., where he applies his expertise in chemical synthesis. His work at the company reflects his commitment to advancing scientific knowledge and developing practical solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Mazhar has collaborated with esteemed colleagues, including Paul Evans and Stanley Michael Roberts. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Mazhar Iqbal's contributions to chemical synthesis and his innovative patent demonstrate his impact on the scientific community. His work continues to inspire advancements in medicine and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…